tiprankstipranks
Krystal Biotech (KRYS)
NASDAQ:KRYS
US Market

Krystal Biotech (KRYS) Income Statement

Compare
463 Followers

Krystal Biotech Income Statement

Last quarter (Q4 2024), Krystal Biotech's total revenue was $91.14M, an increase of 116.26% from the same quarter last year. In Q4, Krystal Biotech's net income was $45.48M. See Krystal Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 290.51M$ 50.70M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 270.45M$ 47.60M$ -4.05M$ -2.77M$ -1.85M
Operating Expenses
$ 204.76M$ 157.33M$ 120.20M$ 68.28M$ 33.00M
Depreciation and Amortization
$ 6.71M$ 5.01M$ 4.05M$ 2.77M$ 1.85M
EBITDA
$ 109.91M$ 17.90M$ -145.20M$ -65.31M$ -30.32M
Operating Income
$ 65.69M$ -109.73M$ -145.20M$ -68.28M$ -33.00M
Other Income/Expenses
$ 29.66M$ 122.62M$ 5.22M$ -1.29M$ 832.00K
Pretax Income
$ 95.36M$ 12.90M$ -139.97M$ -69.57M$ -32.17M
Net Income
$ 89.16M$ 10.93M$ -139.97M$ -69.57M$ -32.17M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 3.12$ 0.40$ -5.49$ -3.13$ -1.71
Diluted EPS
$ 3.00$ 0.39$ -5.49$ -3.13$ -1.71
Weighted Average Shares Outstanding
28.59M 27.15M 25.49M 22.20M 18.79M
Weighted Average Shares Outstanding (Diluted)
29.74M 27.75M 25.49M 22.20M 18.79M
Currency in USD

Krystal Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis